Caption Management’s Fulgent Genetics FLGT Stock Holding History

Caption Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,000	Closed	-$381K	–	1408
2022 Q3	$381K	Buy	+10,000	New	+$501K	0.01%	1129

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Caption Management's FLGT Position: Q4 2022 in Review

Caption Management sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 10,000 shares — an estimated $381K sold.

Caption Management first reported a position in FLGT in Q3 2022 and held it in 1 quarter. The position peaked at $381K in Q3 2022. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

Caption Management reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
Caption Management sold 10,000 Fulgent Genetics shares in Q4 2022, an estimated $381K.
Caption Management first reported a position in Fulgent Genetics in Q3 2022 and held it in 1 quarter.
Caption Management's Fulgent Genetics position peaked at $381K in Q3 2022.
224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.